PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 77 filers reported holding PLIANT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,850,669 | +4.7% | 1,317,801 | +9.4% | 0.00% | 0.0% |
Q2 2023 | $21,833,513 | +182.9% | 1,204,940 | +315.4% | 0.00% | – |
Q1 2023 | $7,716,687 | -23.5% | 290,101 | -44.4% | 0.00% | – |
Q4 2022 | $10,083,494 | +126.0% | 521,650 | +144.2% | 0.00% | – |
Q3 2022 | $4,462,000 | +551.4% | 213,581 | +149.9% | 0.00% | – |
Q2 2022 | $685,000 | -78.1% | 85,468 | -80.9% | 0.00% | – |
Q1 2022 | $3,133,000 | -47.8% | 446,996 | +0.5% | 0.00% | – |
Q4 2021 | $6,002,000 | -14.9% | 444,629 | +6.4% | 0.00% | – |
Q3 2021 | $7,056,000 | -37.1% | 418,003 | +8.6% | 0.00% | -100.0% |
Q2 2021 | $11,211,000 | -25.0% | 385,008 | +1.3% | 0.00% | 0.0% |
Q1 2021 | $14,955,000 | +263.7% | 380,249 | +110.1% | 0.00% | – |
Q4 2020 | $4,112,000 | +51.0% | 180,991 | +50.6% | 0.00% | – |
Q3 2020 | $2,723,000 | – | 120,207 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |